Marine species can now be used for medication purposes and so the research continues. Marine derived compounds are more bioactive than any other species particularly in terms of cytotoxicity. Marine natural products have a stronghold in the domain of anticancer chemotherapy as indicated by researchers. Such compounds have already made to the market or are under clinical research. On the basis of geographic segmentation, the global marine derived drugs market is segmented into North America, Europe, Asia Pacific, and Middle-East & Africa.
Till date, global marine pharmaceutical drugs consist of seven approved pharmaceuticals in clinical use, four of which are anticancer drugs. Cytarabine or Ara-C is the first marine-derived anticancer agent to be developed for clinical use and is a synthetic analogue of a C-nucleoside from Caribbean sponge. Second anticancer marine drug found was tunicate Ecteinascidia turbinate would be utilized for treatment of soft tissue sarcomas and ovarian cancer. The third marine anti-cancer drug was halichondria okadai; which is a simpler structure comprising pharmacophore obtained synthetically.
Browse Detail Market Report @ https://www.millioninsights.com/industry-reports/marine-derived-drugs-market
Eribulin (Halaven) is the most complex marine drug made until date and is used for the treatment of drug refractory breast cancer. The recently approved marine drug namely brentuximab vedotin (Adcetris) is a chimeric antibody coupled with protease-cleavable linker to a derivative of the dolastatin to treat hodgkin’s lymphomas and large cell lymphoma. Thus, marine derived drugs are also found in antiviral drugs to treat various kinds of infections. Much recently, there have been drugs developments for Anticancer, Alzheimer’s disease, and are also used as Antibacterials. Aplidine, Plinabulin and Salinosporamide A have been found for anticancer whereas Bryostatin for Alzheimer’s and Anthracimycin as an Antibacterial.
Commercially, the rising healthcare requirements and the unmet needs are to be addressed by innovative methods. Developed nations have already started taking initiatives in this direction to resolve critical illness using marine compounds. If the research is conducted on a large scale and in joint venture, the global market may witness new avenues in the global healthcare industry.
Request Sample Copy of Market Research @ https://www.millioninsights.com/industry-reports/marine-derived-drugs-market/request-sample
The key driving factors responsible for the growth of marine derived drugs market include growing initiatives for preserving marine biodiversity and investments in research programs worldwide. Additionally, several companies are now gearing up to research various compounds that can cure several disease and illnesses. Industries are now aiming to determine marine organisms and are working towards finding a cure for fatal and high-risk disease in upcoming years. However, less research conducted to study marine elements for clinical purpose is likely to impede the market growth during the forecast period.
Hence, with the prediction for estimated period, the global marine derived drugs industry is bound to emerge in terms of production of drugs, biomaterials and supplements. North America and Europe are anticipated to dominate the global marine derived drugs market during the forecast period owing to the sophisticated infrastructure of healthcare and also due to high awareness with regards to chronic ailments.
APAC regions such as India and China are anticipated to grow at a higher CAGR during the forecast period owing to lucrative opportunities for the global marine derived drugs market. Also the rise in medical tourism in India and China have made them popular destinations for advanced medical care, leading to rise in increasing number of patients from underdeveloped regions. The key players in the global marine derived drugs market include Pharma Marine USA, Genzyme, Bayer Innovation, Abbott Laboratories, Takeda Oncology’s Millennium LLC, Marine Polymer Technologies, Inc., and Xenome Limited.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184
Visit Our Blog: www.millioninsights.blogspot.com